Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CCR5 antagonists(C-C chemokine receptor type 5 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC34H50F2N4O3 |
InChIKeyYZGXEGUSPLSQOJ-MJOCGKAJSA-N |
CAS Registry891824-47-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | CA | - |